A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
Clinical trial NCT03322631 · COMPLETED
Trial details
- NCT number
- NCT03322631
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2018-05-29
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.